Product Information
GNP FEXOFENADINE-PSE ER 60-120 is a generic product labeled by AmerisourceBergen, priced at $0.4832 per EA under NDC 46122069465. Its NADAC has been published 208 times since Oct 12, 2022.
FDA first approved this application on Jan 29, 2015.
GNP FEXOFENADINE-PSE ER 60-120
Fexofenadine Hydrochloride and Pseudoephedrine HydrochlorideStrength
60; 120 mg/1; mg/1
Manufacturer
AmerisourceBergenNDC
46122069465
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090818FDA Approved
1/29/2015
On Market Since
3/1/2018
Pharmacological Classes
Price Statistics
The NADAC for GNP FEXOFENADINE-PSE ER 60-120 has been published 208 times since Oct 12, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4832 per EA |
|---|---|
| All-time high | $0.5597 (Jun 14, 2023) |
| All-time low | $0.4115 (Nov 19, 2025) |
| 52-week high | $0.4832 |
| 52-week low | $0.4115 |
| Median price | $0.4301 |
| Average price | $0.4517 |
| Largest weekly change | +12.7% (Feb 22, 2023) |
| Weeks tracked | 208 |
| Tracking since | Oct 12, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP FEXOFENADINE-PSE ER 60-120?
The current National Average Drug Acquisition Cost (NADAC) for GNP FEXOFENADINE-PSE ER 60-120, manufactured by AmerisourceBergen, is $0.4832 per EA (NDC 46122069465), effective Sep 30, 2026.
How has the price of GNP FEXOFENADINE-PSE ER 60-120 changed over time?
Over the history we have for it, the NADAC for GNP FEXOFENADINE-PSE ER 60-120 has held within roughly two percent of its current level. It has been tracked across 208 weekly CMS publications since Oct 12, 2022.
What are the highest and lowest recorded NADAC prices for GNP FEXOFENADINE-PSE ER 60-120?
Since Oct 12, 2022, the NADAC for GNP FEXOFENADINE-PSE ER 60-120 has ranged from a low of $0.4115 (Nov 19, 2025) to a high of $0.5597 (Jun 14, 2023), with a median of $0.4301 per EA.
Are there cheaper alternatives to GNP FEXOFENADINE-PSE ER 60-120?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GNP FEXOFENADINE-PSE ER 60-120 in a comparable dosage form, but none are currently priced below it.
Who manufactures GNP FEXOFENADINE-PSE ER 60-120?
GNP FEXOFENADINE-PSE ER 60-120 (NDC 46122069465) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.